Physician

Rajini Katipamula Malisetti, MBBS

According to 2025 Medicare claims, Rajini Malisetti, MBBS (NPI: 1619941804) practices medical oncology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Hennepin, MN. This provider's primary affiliated billing organization is MINNESOTA ONCOLOGY HEMATOLOGY, PA (NPI: 1528035995; TIN: 411793418) and primary practice location at 55369-7588. Malisetti is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Malisetti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 199 traditional Medicare patients, billed 68,554 HCPCS/CPT codes, and received $1,217,373 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 817 prescription claims across 134 beneficiaries totaling $2,772,694 in drug costs, led by Revlimid (Lenalidomide). 2022 DME data shows 36 claims. Open Payments data shows 16 records totaling $23,186. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $339,218 to $1,217,373. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $587,414 to $2,772,694. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	278	27,944	$339,218
2016	290	37,838	$385,995
2017	302	52,801	$556,308
2018	309	55,612	$617,169
2019	600	141,026	$1,633,461
2020	436	110,084	$1,369,666
2021	410	121,403	$1,475,393
2022	351	88,466	$1,308,854
2023	292	64,297	$999,126
2024	199	68,554	$1,217,373

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	149	808	$587,414
2016	160	1,017	$1,283,454
2017	177	1,004	$1,353,134
2018	158	818	$1,697,145
2019	157	843	$1,679,413
2020	154	965	$2,506,057
2021	150	947	$2,286,484
2022	165	1,117	$2,715,587
2023	192	1,034	$2,329,172
2024	134	817	$2,772,694

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	144	$6,537
2016	N/R	194	$42,448
2017	N/R	24	$7,913
2018	N/R	N/R	N/R
2019	N/R	12	$2,921
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	36	$1,418
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	32	128	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	58	101	$100
80053	Blood test, comprehensive group of blood chemicals	71	158	$10
36415	Insertion of needle into vein for collection of blood sample	76	230	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	81	241	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	49	1,372	$909,111
Calquence	Acalabrutinib Maleate	36	1,080	$359,687
Pomalyst	Pomalidomide	15	420	$320,529
Ibrance	Palbociclib	21	588	$318,929
Imbruvica	Ibrutinib	21	604	$293,173

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	16	$23,186	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rajini Katipamula Malisetti, MBBS?

Tedicare shows public-source Medicare data for Rajini Katipamula Malisetti, MBBS (NPI 1619941804), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajini Katipamula Malisetti, MBBS have ACO affiliation data?

Rajini Katipamula Malisetti, MBBS is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Rajini Katipamula Malisetti, MBBS?

Rajini Katipamula Malisetti, MBBS is linked to MINNESOTA ONCOLOGY HEMATOLOGY, PA (billing NPI 1528035995) in the available physician profile data.

Does Rajini Katipamula Malisetti, MBBS have Open Payments data?

Rajini Katipamula Malisetti, MBBS has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.